Crescent Capital BDC (CCAP) Expected to Announce Quarterly Earnings on Monday

Crescent Capital BDC (NASDAQ:CCAP) is projected to announce its Q3 2026 results after the market closes on Monday, November 9th. Analysts expect Crescent Capital BDC to post earnings of $0.35 per share and revenue of $36.37 million for the quarter. Individuals may visit the company’s upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Tuesday, November 10, 2026 at 12:00 PM ET.

Crescent Capital BDC (NASDAQ:CCAP) last issued its quarterly earnings results on Monday, August 10th. The company reported $0.36 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.37 by ($0.01). Crescent Capital BDC had a negative net margin of 2.02% and a positive return on equity of 9.02%. The firm had revenue of $5.12 million for the quarter, compared to the consensus estimate of $37.12 million. On average, analysts expect Crescent Capital BDC to post $1.49 EPS for the current fiscal year and $1.42 EPS for the next fiscal year.

Crescent Capital BDC Stock Performance

Shares of CCAP stock traded down $0.13 during mid-day trading on Tuesday, reaching $9.28. The stock had a trading volume of 55,900 shares, compared to its average volume of 230,156. Crescent Capital BDC has a one year low of $8.40 and a one year high of $15.18. The firm has a market cap of $341.78 million, a PE ratio of -103.07 and a beta of 0.57. The firm’s 50 day simple moving average is $9.57 and its 200 day simple moving average is $11.69. The company has a quick ratio of 1.30, a current ratio of 1.30 and a debt-to-equity ratio of 1.41.

Crescent Capital BDC Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, October 15th. Investors of record on Wednesday, September 30th were paid a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 14.7%. The ex-dividend date was Wednesday, September 30th. Crescent Capital BDC’s dividend payout ratio is presently -1,511.11%.

Analysts Set New Price Targets

Several research analysts recently commented on the company. Zacks Research raised Crescent Capital BDC from a “strong sell” rating to a “hold” rating in a research report on Tuesday, July 21st. Keefe, Bruyette & Woods cut shares of Crescent Capital BDC from an “outperform” rating to a “market perform” rating and dropped their price objective for the company from $13.00 to $12.00 in a research note on Monday, August 17th. Raymond James Financial set a $10.00 price objective on shares of Crescent Capital BDC in a report on Thursday, October 22nd. Wells Fargo & Company decreased their target price on shares of Crescent Capital BDC from $12.00 to $11.00 and set an “equal weight” rating on the stock in a research report on Wednesday, August 12th. Finally, Bank of America cut shares of Crescent Capital BDC from a “buy” rating to a “neutral” rating and lowered their target price for the company from $13.00 to $10.25 in a research note on Thursday, September 10th. One equities research analyst has rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $12.25.

Insider Activity at Crescent Capital BDC

In related news, major shareholder & Guaranty Life Insur Fidelity sold 139,054 shares of the business’s stock in a transaction on Wednesday, September 9th. The stock was sold at an average price of $10.23, for a total value of $1,422,522.42. Following the sale, the insider owned 3,680,307 shares of the company’s stock, valued at $37,649,540.61. The trade was a 3.64% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 451,543 shares of company stock worth $4,689,738. 1.23% of the stock is owned by company insiders.

About Crescent Capital BDC

Crescent Capital BDC, Inc is a business development company that provides financing to middle-market companies. The company seeks to generate current income and, to a lesser extent, capital appreciation by investing in privately negotiated debt and equity securities.

Its investment portfolio is focused primarily on senior secured loans, including first-lien and second-lien loans, as well as other debt investments and selected equity interests. Crescent Capital BDC generally works with established companies across a range of industries, providing capital for acquisitions, recapitalizations, refinancing, growth initiatives and other corporate purposes.

The company is externally managed by Crescent Cap Advisors LLC, an affiliate of Crescent Capital Group LP, an investment firm specializing in credit and alternative investments.